期刊文献+

联合治疗对老年类风湿关节炎患者血脂的影响 被引量:7

Effect of combination therapy on serum lipids in elderly patients with rheumatoid arthritis
原文传递
导出
摘要 目的研究甲氨蝶呤、柳氮磺吡啶、硫酸羟氯喹联合治疗对老年类风湿关节炎患者疾病活动相关指标和血脂的影响。方法老年类风湿关节炎患者随机分为A、B组,每组68例,A组联合应用甲氨蝶呤、柳氮磺吡啶、硫酸羟氯喹治疗并配合一定的生活方式干预,B组则在A组用药基础上加用血脂康。检测两组治疗前和治疗6个月后胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)、C-反应蛋白(CRP)和血沉(ESR),以DAS28、关节肿胀指数、关节压痛指数、晨僵时间来评定疾病活动度。结果治疗后两组TC、TG、LDL-C均低于治疗前,HDL-C水平高于治疗前(均P〈O.05);DAS28、ESR、CRP、关节压痛数、关节肿胀数和晨僵时间较治疗前明显降低(均P〈0.05),治疗后两组间上述指标差异均无统计学意义。两组患者治疗后均未出现明显肝、肾功能损害等不良反应。结论RA患者存在血脂水平异常,慢作用抗风湿药在缓解病情的同时,对于老年患者血脂有一定的影响。 Objective To observe the effect of combination therapy with methotrexate, sulfasalazine and hydroxychloroquine on serum lipids in elderly patients with rheumatoid arthritis (RA). Methods 136 patients with RA were randomly divided into group A and group B (n=68, each). Patients in group A were treated with methotrexate, sulfasalazine and hydroxychloroquine sulfate plus life style intervention. Patients in group B were treated with the therapy as same as that of group A and received xuezhikang additionally. The levels of cholesterol (TC), low density lipoprotein cholesterol (LDL-C), triglyceride (TG), high density lipoprotein cholesterol (HDL-C), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) were determined before and 6 months after treatment. Disease activity was assessed by DAS28, swelling index, joint pain index, duration of morning stiffness. Results The levels of TC, TG and LDL-C were lower and HDL-C level was higher in the two groups after 6 months of the treatment than before treatment (all P〈 0.05). DAS28, ESR, CRP, joint tenderness, joint swelling and duration of morning stiffness were significantly reduced in two groups after 6 months of the treatment as compared with pretreatment (all P〈0.05). There was no significant difference in levels of TC, TG, LDL-C, HDL-C, DAS28, ESR, CRP, joint tenderness, joint swelling and duration of morning stiffness between the two groups after treatment. There were no obvious differences in liver and kidney function between the two groups before and after treatment. Conclusions Blood lipids levels are abnormal in RA patients. The slow acting antirheumatic drugs have certain effect on blood lipids when alleviating disease symptoms.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2013年第11期1198-1201,共4页 Chinese Journal of Geriatrics
关键词 关节炎 类风湿 血脂异常 Arthritis,rheumatoid Dyslipidemias
  • 相关文献

参考文献13

  • 1Liao KP, Solomon DH. Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis. Rheumatology (Oxford), 2013, 52:45-52.
  • 2Daien CI, Fesler P. Rheumatoid arthritis: a cardiovascular disease? Ann Cardiol Angeiol (Paris),2012,61:111-117.
  • 3Amett FC, Edworthy SM, Bloch DA, et al. The American Rheumatoid Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rherm, 1988, 31 : 315-324.
  • 4Shoenfeld Y, Gerli R, Doria A, et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation, 2005, 112:3337-3347.
  • 5Avina-Zubita JA, Choi HK, Sadatsafavi M, et al. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum, 2008, 59:1690-1697.
  • 6Zhao Q. Inflammation, autoimmunity, and atherosclerosis. Discov Med, 2009,8: 7-12.
  • 7Pereira I, Laurindo I, Burlingame R, et al. Auto- antibodies do not influence development of atherosclerotic plaques in rheumatoid arthritis. Joint Bone Spine, 2008,75 : 416-421.
  • 8Knowlton N, Wages JA, Centola MB, et al. Apolipoprotein B-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis. Arthritis Care Res ( Hoboken), 2012,64:993-1000.
  • 9Dursunoglu D, Evrengal H, Polat B, et al. Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation. Rheumatol Int,2005,25:241-245.
  • 10薛超,刘文玲,孙艺红,丁荣晶,胡大一.炎症及免疫指标对类风湿关节炎患者血脂的影响分析[J].中华心血管病杂志,2011,39(10):941-945. 被引量:19

二级参考文献50

共引文献58

同被引文献64

  • 1颜彦,王翔飞,张庆勇,崔杰峰,王颉,朱文青,钱菊英,葛均波.来氟米特对家兔动脉粥样硬化形成的影响[J].中国动脉硬化杂志,2005,13(4):432-434. 被引量:3
  • 2王豫巍,王永钧.白芍总苷在自身免疫性疾病中的药理研究与临床应用[J].浙江中医药大学学报,2007,31(2):240-241. 被引量:52
  • 3吴婵媛,曾小峰.白芍总苷对类风湿关节炎滑膜细胞增殖及分泌作用的研究[J].中华风湿病学杂志,2007,11(10):620-622. 被引量:9
  • 4Ross R. Atherosclerosis--an inflammatory disease[J]. N Engl J Med,1999,340:115-126.
  • 5Hulimann D, Enseleit F, Rusehitzka F. Rheumatoid arthritis, in-flammation, and atherosele- rosis [J]. Herz, 2004,29 : 760-768.
  • 6DaneshJ, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease[J]. N Engl J Med,2004,350:1387-1397.
  • 7Solomon DH, Garg R, Lu B, et al. The effect of hydroxychloroquine on insulin sensitivity and lipid parameters in rheumatoid arthritis patients without diabetes mellitus: a randomized, blinded crossover trial[J]. Arthritis Care Res(Hoboken), 2014, 66: 1246-1251.
  • 8Toms TE, Panoulas VF, Douglas KM, et al. Are lipid ratios less susceptible to change with systemic inflammation than individual lipid components in patients with rheumatoid arthritis? [J]. Angiology, 2011, 62: 167-175.
  • 9Peters MJ, Vis M, van Halm VP, et al. Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis[J]. Ann Rheum Dis, 2007, 66:958-961.
  • 10Pereira I, Laurindo I, Burlingame R, et al. Autoantibodies do not influence development of atherosclerotic plaques in rheumatoid arthritis [J]. Joint Bone Spine,2008,75:416-421.

引证文献7

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部